Incyte targeted drug with chemotherapy induces lasting tumor responses in pancreatic cancer patients

A targeted drug from Incyte, used in combination with chemotherapy, induced lasting tumor responses in certain patients with pancreatic cancer, according to a report.

Detected & updated continuously · Source: Nebula